A dose escalation study of gemcitabine plus oxaliplatin in combination with imatinib for gemcitabine-refractory advanced pancreatic adenocarcinoma (English)
- New search for: Starling, N.
- New search for: Hawkes, E. A.
- New search for: Chau, I.
- New search for: Watkins, D.
- New search for: Thomas, J.
- New search for: Webb, J.
- New search for: Brown, G.
- New search for: Thomas, K.
- New search for: Barbachano, Y.
- New search for: Oates, J.
- New search for: Starling, N.
- New search for: Hawkes, E. A.
- New search for: Chau, I.
- New search for: Watkins, D.
- New search for: Thomas, J.
- New search for: Webb, J.
- New search for: Brown, G.
- New search for: Thomas, K.
- New search for: Barbachano, Y.
- New search for: Oates, J.
In:
ANNALS OF ONCOLOGY
;
23
, 4
;
942-947
;
2012
-
ISSN:
- Article (Journal) / Print
-
Title:A dose escalation study of gemcitabine plus oxaliplatin in combination with imatinib for gemcitabine-refractory advanced pancreatic adenocarcinoma
-
Contributors:Starling, N. ( author ) / Hawkes, E. A. ( author ) / Chau, I. ( author ) / Watkins, D. ( author ) / Thomas, J. ( author ) / Webb, J. ( author ) / Brown, G. ( author ) / Thomas, K. ( author ) / Barbachano, Y. ( author ) / Oates, J. ( author )
-
Published in:ANNALS OF ONCOLOGY ; 23, 4 ; 942-947
-
Publisher:
- New search for: OXFORD UNIVERSITY PRESS
-
Publication date:2012-01-01
-
Size:6 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.992
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.992 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 23, Issue 4
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 813
-
Salvage or savage chemotherapy for poor-risk or relapsed testis cancer-20 years later, not much has changedRaghavan, D. et al. | 2012
- 815
-
Intensified chemotherapy with stem-cell rescue in germ-cell tumorsSimonelli, M. / Rosti, G. / Banna, G. L. / Pedrazzoli, P. et al. | 2012
- 823
-
Diagnosis of invasive fungal infections in hematology and oncology-guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO)Ruhnke, M. / Bohme, A. / Buchheidt, D. / Cornely, O. / Donhuijsen, K. / Einsele, H. / Enzensberger, R. / Hebart, H. / Heussel, C. P. / Horger, M. et al. | 2012
- 834
-
Imaging bone metastases in breast cancer: evidence on comparative test accuracyHoussami, N. / Costelloe, C. M. et al. | 2012
- 843
-
Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studiesAune, D. / Greenwood, D. C. / Chan, D. S. / Vieira, R. / Vieira, A. R. / Navarro Rosenblatt, D. A. / Cade, J. E. / Burley, V. J. / Norat, T. et al. | 2012
- 853
-
Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countriesSaini, K. S. / Taylor, C. / Ramirez, A. J. / Palmieri, C. / Gunnarsson, U. / Schmoll, H. J. / Dolci, S. M. / Ghenne, C. / Metzger-Filho, O. / Skrzypski, M. et al. | 2012
- 860
-
A metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumour responses to chemotherapyStebbing, J. / Sharma, A. / North, B. / Athersuch, T. J. / Zebrowski, A. / Pchejetski, D. / Coombes, R. C. / Nicholson, J. K. / Keun, H. C. et al. | 2012
- 866
-
Does trauma or an intercurrent surgical intervention lead to a short-term increase in breast cancer recurrence rates?Allawi, Z. / Cuzick, J. / Baum, M. et al. | 2012
- 870
-
Identifying factors that impact survival among women with inflammatory breast cancerDawood, S. / Ueno, N. T. / Valero, V. / Woodward, W. A. / Buchholz, T. A. / Hortobagyi, G. N. / Gonzalez-Angulo, A. M. / Cristofanilli, M. et al. | 2012
- 876
-
Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality?Yerushalmi, R. / Tyldesley, S. / Woods, R. / Kennecke, H. F. / Speers, C. / Gelmon, K. A. et al. | 2012
- 882
-
Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: determinants of interruptions vary over timeCluze, C. / Rey, D. / Huiart, L. / BenDiane, M. K. / Bouhnik, A. D. / Berenger, C. / Carrieri, M. P. / Giorgi, R. et al. | 2012
- 891
-
Recurrence risk score based on the specific activity of CDK1 and CDK2 predicts response to neoadjuvant paclitaxel followed by 5-fluorouracil, epirubicin and cyclophosphamide in breast cancersKim, S. J. / Nakayama, S. / Shimazu, K. / Tamaki, Y. / Akazawa, K. / Tsukamoto, F. / Torikoshi, Y. / Matsushima, T. / Shibayama, M. / Ishihara, H. et al. | 2012
- 897
-
Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factorsSerrano, C. / Cortes, J. / De Mattos-Arruda, L. / Bellet, M. / Gomez, P. / Saura, C. / Perez, J. / Vidal, M. / Munoz-Couselo, E. / Carreras, M. J. et al. | 2012
- 903
-
Laparoscopic versus open radical hysterectomy in early-stage cervical cancer: long-term survival outcomes in a matched cohort studyNam, J. H. / Park, J. Y. / Kim, D. Y. / Kim, J. H. / Kim, Y. M. / Kim, Y. T. et al. | 2012
- 911
-
Adjuvant capecitabine chemotherapy using a tailored-dose strategy in elderly patients with colon cancerChang, H. J. / Lee, K. W. / Kim, J. H. / Bang, S. M. / Kim, Y. J. / Kim, D. W. / Kang, S. B. / Lee, J. S. et al. | 2012
- 919
-
Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumabdaggerMalka, D. / Boige, V. / Jacques, N. / Vimond, N. / Adenis, A. / Boucher, E. / Pierga, J. Y. / Conroy, T. / Chauffert, B. / Francois, E. et al. | 2012
- 927
-
Autoimmune disease and subsequent digestive tract cancer by histologyHemminki, K. / Liu, X. / Ji, J. / Sundquist, J. / Sundquist, K. et al. | 2012
- 933
-
Cediranib in combination with mFOLFOX6 in Japanese patients with metastatic colorectal cancer: results from the randomised phase II part of a phase I/II studyKato, T. / Muro, K. / Yamaguchi, K. / Bando, H. / Hazama, S. / Amagai, K. / Baba, H. / Denda, T. / Shi, X. / Fukase, K. et al. | 2012
- 942
-
A dose escalation study of gemcitabine plus oxaliplatin in combination with imatinib for gemcitabine-refractory advanced pancreatic adenocarcinomaStarling, N. / Hawkes, E. A. / Chau, I. / Watkins, D. / Thomas, J. / Webb, J. / Brown, G. / Thomas, K. / Barbachano, Y. / Oates, J. et al. | 2012
- 948
-
The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapySuzuki, C. / Blomqvist, L. / Sundin, A. / Jacobsson, H. / Bystrom, P. / Berglund, A. / Nygren, P. / Glimelius, B. et al. | 2012
- 954
-
Treatment and survival of patients with small-cell lung cancer: small steps forward, but not for patients >80Janssen-Heijnen, M. L. / Maas, H. A. / Siesling, S. / Koning, C. C. / Coebergh, J. W. / Groen, H. J. et al. | 2012
- 961
-
The influence of platinum pathway polymorphisms on the outcome in patients with malignant mesotheliomaErculj, N. / Kovac, V. / Hmeljak, J. / Dolzan, V. et al. | 2012
- 968
-
A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancerTolcher, A. W. / Quinn, D. I. / Ferrari, A. / Ahmann, F. / Giaccone, G. / Drake, T. / Keating, A. / de Bono, J. S. et al. | 2012
- 973
-
Distribution of metastatic sites in renal cell carcinoma: a population-based analysisBianchi, M. / Sun, M. / Jeldres, C. / Shariat, S. F. / Trinh, Q. D. / Briganti, A. / Tian, Z. / Schmitges, J. / Graefen, M. / Perrotte, P. et al. | 2012
- 981
-
The polymorphisms in the VHL and HIF1A genes are associated with the prognosis but not the development of renal cell carcinomaQin, C. / Cao, Q. / Ju, X. / Wang, M. / Meng, X. / Zhu, J. / Yan, F. / Li, P. / Ding, Q. / Chen, J. et al. | 2012
- 990
-
Induction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin: a randomized phase II trial in elderly patientsBrunnberg, U. / Mohr, M. / Noppeney, R. / Durk, H. A. / Sauerland, M. C. / Muller-Tidow, C. / Krug, U. / Koschmieder, S. / Kessler, T. / Mesters, R. M. et al. | 2012
- 997
-
A phase II study evaluating the safety and efficacy of an adenovirus-DLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinomaChia, W. K. / Wang, W. W. / Teo, M. / Tai, W. M. / Lim, W. T. / Tan, E. H. / Leong, S. S. / Sun, L. / Chen, J. J. / Gottschalk, S. et al. | 2012
- 1005
-
Erlotinib and chemoradiation in patients with surgically resected locally advanced squamous cell carcinoma of the head and neck: a GICOR phase I trialArias de la Vega, F. / Contreras, J. / de las Heras, M. / de la Torre, A. / Arrazubi, V. / Herruzo, I. / Prieto, I. / Garcia-Saenz, J. A. / Romero, J. / Calvo, F. A. et al. | 2012
- 1010
-
Gefitinib, cisplatin, and concurrent radiotherapy for locally advanced head and neck cancer: EGFR FISH, protein expression, and mutational status are not predictive biomarkersTan, E. H. / Goh, C. / Lim, W. T. / Soo, K. C. / Khoo, M. L. / Tan, T. / Tan, D. S. / Ang, M. K. / Ng, Q. S. / Tan, P. H. et al. | 2012
- 1016
-
Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neckHitt, R. / Irigoyen, A. / Cortes-Funes, H. / Grau, J. J. / Garcia-Saenz, J. A. / Cruz-Hernandez, J. J. et al. | 2012
- 1023
-
Phase I study of continuous and intermittent schedules of lapatinib in combination with vinorelbine in solid tumorsChew, H. K. / Somlo, G. / Mack, P. C. / Gitlitz, B. / Gandour-Edwards, R. / Christensen, S. / Linden, H. / Solis, L. J. / Yang, X. / Davies, A. M. et al. | 2012
- 1030
-
Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasisFasol, U. / Frost, A. / Buchert, M. / Arends, J. / Fiedler, U. / Scharr, D. / Scheuenpflug, J. / Mross, K. et al. | 2012
- 1037
-
Phase I study of the effects of renal impairment on the pharmacokinetics and safety of satraplatin in patients with refractory solid tumorsGalsky, M. D. / Camacho, L. H. / Chiorean, E. G. / Mulkerin, D. / Hong, D. S. / Oh, W. K. / Bajorin, D. F. et al. | 2012
- 1044
-
European cancer mortality predictions for the year 2012Malvezzi, M. / Bertuccio, P. / Levi, F. / La Vecchia, C. / Negri, E. et al. | 2012
- 1053
-
Role of medical history and medication use in the aetiology of upper aerodigestive tract cancers in Europe: the ARCAGE studyMacfarlane, T. V. / Macfarlane, G. J. / Thakker, N. S. / Benhamou, S. / Bouchardy, C. / Ahrens, W. / Pohlabeln, H. / Lagiou, P. / Lagiou, A. / Castellsague, X. et al. | 2012
- 1061
-
Inverse association between soy intake and non-Hodgkin lymphoma risk among women: a case-control study in JapanChihara, D. / Matsuo, K. / Kanda, J. / Hosono, S. / Ito, H. / Nakamura, S. / Seto, M. / Morishima, Y. / Tajima, K. / Tanaka, H. et al. | 2012
- 1067
-
Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomasGronchi, A. / Miceli, R. / Colombo, C. / Stacchiotti, S. / Collini, P. / Mariani, L. / Sangalli, C. / Radaelli, S. / Sanfilippo, R. / Fiore, M. et al. | 2012
- 1074
-
Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized studyJouary, T. / Leyral, C. / Dreno, B. / Doussau, A. / Sassolas, B. / Beylot-Barry, M. / Renaud-Vilmer, C. / Guillot, B. / Bernard, P. / Lok, C. et al. | 2012
- 1081
-
A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptorCampanati, A. / Berardi, R. / Onofri, A. / Pierantoni, C. / Conte, I. / Giuliodori, K. / Molinelli, E. / Marcucci, F. / Cascinu, S. / Offidani, A. et al. | 2012